openPR Logo
Press release

Global Cerebrospinal Fluid Management Market to Reach 1.9 US$ billion by 2023 growing at 5.5 % CAGR

07-03-2018 09:50 AM CET | Health & Medicine

Press release from: iHealthcareAnalyst, Inc.

Global Cerebrospinal Fluid Management Market to Reach 1.9 US$

According to a new market research report (updated 2018) published by iHealthcareAnalyst, Inc., Cerebrospinal Fluid Management Market – Global CSF Products Analysis and Forecast 2018-2023, the global cerebrospinal fluid management market was valued at US$ 1,045 Million in 2013 and to reach US$ 1.9 billion by 2023, growing at a CAGR of 5.5% from 2018-2023.

Visit the Global Cerebrospinal Fluid Management Market – Global Patient Solutions, System Strengthening and End Users Analysis and Forecast 2015-2023 report at

Cerebrospinal fluid (CSF) is a clear, colorless body fluid found in the brain and spine which acts as a cushion or buffer for the brain's cortex, providing basic mechanical and immunological protection to the brain inside the skull. The CSF also serves a vital function in cerebral autoregulation of cerebral blood flow. The cerebrospinal fluid management market report provides market size estimates (US$ million 2015-2023) for key market segments based on CSF product type (CSF shunts), CSF drainage systems (ventricular drainage system, lumbar drainage system), and also forecast (CAGR% 2018-2023). It also provides the detailed market landscape and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and/or services offered, and recent trends in strategic management.

The global cerebrospinal fluid management market is segmented as:

1. CSF Product Type
1.1. CSF Shunts

2. CSF Drainage Systems
2.1. Ventricular Drainage System
2.2. Lumbar Drainage System

3. Geography (Region, Country)
3.1. North America (U.S., Canada)
3.2. Latin America (Brazil, Mexico, Rest of LA)
3.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
3.4. Asia Pacific (Japan, China, India, Rest of APAC)
3.5. Rest of the World

4. Company profiles
4.1. B. Braun Melsungen AG
4.2. BeckerSmith Medical, Inc.
4.3. DePuy Synthes (J&J)
4.4. Integra LifeSciences Holding Corporation
4.5. Medtronic plc.
4.6. Möller Medical GmbH
4.7. Sophysa S.A.
4.8. Spiegelberg GmbH & Co. KG

iHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.

In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study.

Ana Aitawa
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Cerebrospinal Fluid Management Market to Reach 1.9 US$ billion by 2023 growing at 5.5 % CAGR here

News-ID: 1106821 • Views: 562

More Releases from iHealthcareAnalyst, Inc.

Global Amyotrophic Lateral Sclerosis Devices Market $19.5 Billion by 2029
The global market for amyotrophic lateral sclerosis devices or motor neuron disease devices anticipated to reach $19.5 billion by 2029, growing at a CAGR of 7.3% over the forecast period, driven by increasing incidence, rising geriatric population, lack of curative treatment, growing public awareness, and technological advancements in palliative care. Amyotrophic lateral sclerosis or Lou Gehrig's disease or motor neuron disease (MND) is characterized by progressive degeneration of the motor nerve
Global Blood Gas Monitoring Products Market Growing at CAGR of 6.2% to Reach $5. …
The global market for blood gas monitoring products is estimated to reach $5.5 billion by the end of 2025, expanding at a CAGR of 6.2% during the forecast period, supported by growing geriatric population, rising prevalence of chronic diseases, and technological advances. The global blood gas monitoring devices market research report provides market size (Revenue US$ Million 2017 to 2025), market share analysis, growth trends and forecast (CAGR%, 2019 to 2025).
Advances in Mobile Connectivity Services to Drive Telemedicine Technologies and …
According to a new market research report Telemedicine Technologies and Services Market 2015-2023 published by iHealthcareAnalyst, Inc., the global computer-aided detection market to reach US$ 73.2 Billion by 2023, expanding at a CAGR of 13.5% from 2018-2023. Visit the Global Telemedicine Technologies and Services Market Analysis and Forecast 2018-2023 report at The global telemedicine technologies and services market newly published (updated 2018) report estimates the market size (US$ million 2015-2023)
Global Internet Pharmacies Market to Cross US$ 100 Billion by 2023
The global internet pharmacies market is estimated to reach US$ 106 Billion by 2023, growing at a CAGR of 15.7% over the forecast period, driven by rising personal disposable income, lower prices, surge in internet penetration, stupendous growth of online retail market and a large number of online players entering the online healthcare product segment. The major players are in a race to increase their share in the industry by

All 5 Releases

More Releases for CSF

G-CSF and G-CSF Biosimilars Market Size, Growth and Forecast 2021 to 2028 By Ame …
The worldwide G-CSF and G-CSF Biosimilars market report is the very much investigated answer for the chiefs and academicians who are looking for a definite examination regarding both subjective just as quantitative, for the notable time frame and for the impending years gauge. The exploration report includes the business outline alongside the approaching dangers and supporting components that will drive or hamper the market development and give open doors sooner
G-CSF and G-CSF Biosimilars Market Size to Witness Huge Growth by 2027: Pfizer, …
G-CSF and G-CSF Biosimilars market Research Report LOS ANGELES, United States: QY Research offers an overarching research and analysis-based study on, “Global G-CSF and G-CSF Biosimilars Market Report, History and Forecast 2016-2027, Breakdown Data by Manufacturers, Key Regions, Types and Application“. This report offers an insightful take on the drivers and restraints present in the market. G-CSF and G-CSF Biosimilars data reports also provide a 5 year pre-historic and forecast
Global G-CSF And G-CSF Biosimilars Market 2025| By Top Key Players Pfizer, Novar …
G-CSF, which is also known as filgrastim, is a growth factor used to aid the recovery of bone marrow after chemotherapy treatment for cancer, especially in patients with neutropenia (low white blood cell count in the blood), which causes reduced resistance to infections. It can also be used to stimulate mobilization of haematopoietic stem cells for collection and transplantation. Request Sample Copy of Report @ This report studies
Trends in Cerebrospinal Fluid (CSF) Management Market
The global cerebrospinal fluid management market is foreseen to experience a tremendous growth within the forecast period from 2015 to 2023. The organizations are carrying out mergers and acquisitions, regional expansion, strategic tie-ups, and new product launches, with a specific end goal to manage their position in the market. For example, in 2015, Codman Neuro (working unit of Johnson and Johnson Services, Inc.) presented a novel MRI-safe programmable valve with
Cerebrospinal Fluid (CSF) Management Market (Product - CSF Shunts and CSF Draina …
Albany, NY, 5th September : Recent research and the current scenario as well as future market potential of " Trend of Cerebrospinal Fluid (CSF) Management Market in Global Industry : Market Development, Analysis and Overview 2017 " globally. Hydrocephalus is defined as an abnormal increase in the amount of cerebrospinal fluid inside the cranial cavity accompanied with enlargement of cerebral ventricles, which frequently leads to intracranial pressure and skull enlargement. Get PDF
China CSF Management Market Outlook to 2023
New report, "China CSF Management Market Outlook to 2023", provides key market data on theChina CSF Management market. The report provides value, in millions of US dollars, volume (in units) and and average prices (USD) within market segments - Hydrocephalus Shunts and Dura Substitutes. The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on